Troglitazone stimulates β-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor
- 11 June 2010
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 396 (4) , 921-926
- https://doi.org/10.1016/j.bbrc.2010.05.023
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- β-Arrestin Mediates β1-Adrenergic Receptor-Epidermal Growth Factor Receptor Interaction and Downstream SignalingJournal of Biological Chemistry, 2009
- β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD PhosphorylationJournal of Biological Chemistry, 2009
- β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivationProceedings of the National Academy of Sciences, 2008
- A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signalingProceedings of the National Academy of Sciences, 2007
- β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotectionJournal of Clinical Investigation, 2007
- Synergistic vascular protective effects of combined low doses of PPARα and PPARγ activators in angiotensin II‐induced hypertension in ratsBritish Journal of Pharmacology, 2007
- β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytesProceedings of the National Academy of Sciences, 2006
- Peroxisome Proliferator–Activated Receptor γ Regulates Angiotensin II–Stimulated Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase in Blood Vessels In VivoHypertension, 2006
- Dual Inhibition of β-Adrenergic and Angiotensin II Receptors by a Single AntagonistCirculation, 2003
- Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted MicePublished by Elsevier ,1998